Food News and Research

RSS

IOM report identifies options that could further improve information obtained from pediatric studies

Federal laws that motivate or require drug and biologic developers to conduct pediatric studies have yielded beneficial information to guide the use of medications in children, says a new report by the Institute of Medicine. Still, studies involving children continue to be limited, especially in certain areas such as medications' use in newborns and long-term safety and effectiveness in children.

1 Mar 2012

First Edition: March 1, 2012

Today's headlines set the stage for the Senate's scheduled vote on a measure sponsored by Sen. Roy Blunt, R-Mo., that would allow employers and insurers to opt out of provisions in Obama's health care law to which they object on religious or moral grounds.

1 Mar 2012

Gluten-free, casein-free diet more effective in improving ASD behaviors and symptoms

A gluten-free, casein-free diet may lead to improvements in behavior and physiological symptoms in some children diagnosed with an autism spectrum disorder (ASD), according to researchers at Penn State. The research is the first to use survey data from parents to document the effectiveness of a gluten-free, casein-free diet on children with ASD.

1 Mar 2012

New portable device can quickly diagnose infectious disease

Infectious diseases can spread very rapidly, so quickly identifying them can be crucial to stopping an epidemic. However, current testing for such diseases can take hours and days. But not for much longer.

1 Mar 2012

Aspirin may help postmenopausal women reduce risk of trans fat-related stroke

New research shows an increased risk of ischemic stroke in postmenopausal women who consume higher amounts of trans fatty acids, commonly found in baked goods, fried foods, and packaged products. Study findings now available in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association and Child Neurology Society, suggest aspirin use may moderate the stroke risk caused by a diet high in trans fats.

1 Mar 2012

Ruxolitinib boosts QOL and survival for patients with myelofibrosis

A drug that relieves the severe symptoms of a life-threatening bone marrow cancer called myelofibrosis also improves the survival of patients with the disease, according to a phase III clinical trial published in the March 1 edition of New England Journal of Medicine.

1 Mar 2012

Aspirin may reduce risk of trans fat-related stroke in older women

Older women whose diets include a substantial amount of trans fats are more likely than their counterparts to suffer an ischemic stroke, a new study shows.

1 Mar 2012

Glucose meter could be adapted to monitor DNA

An inexpensive device used by millions of people with diabetes could be adapted into a home DNA detector that enables individuals to perform home tests for viruses and bacteria in human body fluids, in food and in other substances, scientists are reporting in a new study.

1 Mar 2012

FDA revises safety information on statin labels

The United States Food and Drug Administration (FDA) announced it is revising safety information on the labels of some statins (cholesterol lowering drugs).

1 Mar 2012

NEJM publishes results from two Jakafi Phase III studies on MF

The New England Journal of Medicine (NEJM) today published results from two Phase III studies (COMFORT-I and COMFORT-II) of Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor recently approved by the Food and Drug Administration (FDA) for the treatment of intermediate or high-risk myelofibrosis.

1 Mar 2012

FDA extends action date for Bristol-Myers Squibb, Pfizer's Eliquis NDA

Bristol-Myers Squibb Company and Pfizer announced today that the U.S. Food and Drug Administration (FDA) has extended the action date by three months for the New Drug Application (NDA) for Eliquis (apixaban) for the prevention of stroke and systemic embolism in patients with atrial fibrillation.

1 Mar 2012

FDA approves MedImmune's FluMist Quadrivalent vaccine

MedImmune today announced that the U.S. Food and Drug Administration (FDA) has approved FluMist Quadrivalent (Influenza Vaccine Live, Intranasal) for prevention of influenza.

29 Feb 2012

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a lower dose formulation of ANGELIQ (drospirenone and estradiol) tablets to treat moderate to severe vasomotor symptoms due to menopause in women who have a uterus.

29 Feb 2012

Biogen Idec announces new easier to use injection for multiple sclerosis

The Food and Drug Administration approved the company's Avonex pen, an injection designed to reduce pain and anxiety when patients self-administer the drug. The FDA also approved a new dosing schedule for the drug intended to reduce flu-like symptoms often associated with the drug.

29 Feb 2012

Texas doctor caught in a $375 million fraud

A Texas doctor has been accused of running a massive health fraud care scheme with thousands of fraudulent patients and intermediaries allegedly offering cash, food stamps or free groceries, to cheat the Medicare and Medicaid of nearly $375 million.

29 Feb 2012

Americans visiting the ER for dental problems ignoring preventive services: Report

Latest figures show that more Americans are turning to the emergency room for routine dental problems. This choice often costs 10 times more than preventive care and offers far fewer treatment options than a dentist's office. This comes from an analysis of government data and dental research.

29 Feb 2012

Walnuts associated with better memory scores and cognitive function

Do you recall what you ate for breakfast today or dinner last night? According to new research, you may have a better chance of remembering if you include walnuts. Recent findings published in the Journal of Alzheimer's Disease report walnut consumption in a Mediterranean diet is associated with better memory scores and cognitive function.

29 Feb 2012

Wiley-Blackwell to publish 44 new important journals in 2012

In 2012 Wiley-Blackwell, the Scientific, Technical, Medical, and Scholarly publishing business of John Wiley & Sons, Inc., will begin publishing 44 titles new to its journal program, including 16 new launches and 40 journals published in collaboration with societies or other organizations.

29 Feb 2012

Tiny molecule might help protect pancreas from cancer

A tiny molecule might help protect the pancreas from deadly disease and cancer. Tackling a mysterious process: There is a feeling that neglected cancers need more research and Pancreatic cancer is one of the least studied. Today, the survival rate is 3% for five years. Professor Petersen, at the School of Biosciences at Cardiff University, hopes his team's research can change that.

29 Feb 2012

EpiCept fourth quarter revenue decreases to $0.2 million

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2011, and provided an update on the Company's key business initiatives.

29 Feb 2012